New pharmacy player has big plans

Share this article:
A start-up institutional pharmacy company could soon become the market's No. 3 player, according to its executives. The parent group of Golden Living officially launched AlixaRx with predictions it could become a $250 million per year business within 18 months. Ultimately capturing one-fifth or more of the 16,000-nursing home market is a distinct possibility, said AlixaRx President Larry Deans: “If we had 20% of market share [within five years], right now that would be a good goal to shoot for. We believe providers have a need for this service.” AlixaRx's unveiling comes at the detriment of PharMerica, which is losing the Golden Living contracts, company officials said. PharMerica currently has about 20% of the long-term care institutional pharmacy market, which has put it second behind leader Omnicare, which commands approximately 60% of the market, Deans said.
Share this article:

More in Products

Last day to enter McKnight's Tech Awards

Today is the final day to submit entries into the third annual McKnight's Excellence in Technology Awards.

AliMed offers three new fall management products

AliMed offers three new fall management products

AliMed is now offering the AliMed CordLess® Sensor Alarm and the AliMed Worry-Free Fall Alarm to help reduce the risk of accidental falls, and the HipShield® X-tra to help prevent ...

Diamond Wipes creates new wipes

Diamond Wipes creates new wipes

Diamond Wipes has announced an updated version of its Handyclean™ cleaning and sanitizing wipes.